Conception after early IVF pregnancy loss: should we wait?


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 10 08 2020
revised: 11 10 2020
accepted: 29 10 2020
pubmed: 12 12 2020
medline: 27 11 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

Is the interval length between an early pregnancy loss and the following treatment cycle a predictor for achieving clinical pregnancy among IVF patients? This retrospective cohort study of 257 women who reinitiated treatment after first-trimester IVF pregnancy loss was conducted at a tertiary, university-affiliated medical centre between 1 January 2014 to 1 January 2018. Women aged 18-40 years, with normal uterine cavity, who experienced first-trimester pregnancy loss at less than 14 weeks after IVF, were included. Miscarriages were classified as spontaneous, biochemical, medical or surgical. Among 257 women, interval to subsequent IVF treatment was not associated with achieving pregnancy. Patients after biochemical pregnancy (72.7 ± 56.4, median 60 days) or spontaneous miscarriage (97.7 ± 93.1, median 66 days) had shorter intervals to next cycle, compared with medical (111.9 ± 103.2, median 65 days) or surgical (123.4 ± 111.1, median 84 days) (Kaplan-Meier, P = 0.03) miscarriages. Logistic regression analysis showed that the chance of subsequent pregnancy was affected by the number of embryos transferred (P = 0.009) and the type of miscarriage. Medical (P = 0.005) and surgical (P = 0.017) miscarriages were related to lower likelihood of pregnancy compared with biochemical pregnancy (reference group). When pregnancy was achieved in the first post-miscarriage cycle, the chance of live birth increased with shorter intervals (median 57.5 days), whereas second miscarriage was related to longer intervals (median 82.5 days) between miscarriage and subsequent IVF cycle (P = 0.03). On the basis of this cohort, IVF should not be postponed after pregnancy loss, as shorter intervals were associated with greater likelihood of live birth.

Identifiants

pubmed: 33303365
pii: S1472-6483(20)30584-8
doi: 10.1016/j.rbmo.2020.10.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-419

Informations de copyright

Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Maya Sharon-Weiner (M)

Department of Obstetrics and Gynecology, Meir Medical Center, Department of Obstetrics and Gynecology, 59 Tchernichovsky St, Kfar Saba Israel 4428164, Israel; IVF unit, Meir Medical Center, affiliated to the Sackler Faculty of Medicine, Kfar Saba, Israel. Electronic address: swmaya@gmail.com.

Hadar Gluska (H)

Department of Obstetrics and Gynecology, Meir Medical Center, Department of Obstetrics and Gynecology, 59 Tchernichovsky St, Kfar Saba Israel 4428164, Israel.

Sivan Farladansky-Gershenabel (S)

Department of Obstetrics and Gynecology, Meir Medical Center, Department of Obstetrics and Gynecology, 59 Tchernichovsky St, Kfar Saba Israel 4428164, Israel.

Hanoch Schreiber (H)

Department of Obstetrics and Gynecology, Meir Medical Center, Department of Obstetrics and Gynecology, 59 Tchernichovsky St, Kfar Saba Israel 4428164, Israel.

Amir Wiser (A)

Department of Obstetrics and Gynecology, Meir Medical Center, Department of Obstetrics and Gynecology, 59 Tchernichovsky St, Kfar Saba Israel 4428164, Israel; IVF unit, Meir Medical Center, affiliated to the Sackler Faculty of Medicine, Kfar Saba, Israel.

Adrian Shulman (A)

Department of Obstetrics and Gynecology, Meir Medical Center, Department of Obstetrics and Gynecology, 59 Tchernichovsky St, Kfar Saba Israel 4428164, Israel; IVF unit, Meir Medical Center, affiliated to the Sackler Faculty of Medicine, Kfar Saba, Israel.

Anat Hershko-Klement (A)

IVF unit, Hadassah Hospital - Mount Scopus, affiliated with the Hebrew University of Jerusalem Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH